The Evolution of Skin Cancer Treatment: How SRT-100 Vision is Changing the Game in Non-Invasive Skin Cancer Treatment
Skin cancer, particularly non-melanoma skin cancer (NMSC), is one of the most common cancers worldwide. Traditionally, treatments for NMSC have included surgery, radiation, and topical therapies. However, recent innovations have revolutionized the way we approach this disease, with one of the most promising advancements in non-invasive skin cancer treatment: the SRT-100 Vision. The SRT-100 Vision […]
Introducing the Fair Deal Agreement: Revolutionizing Dermatology Practices with Sensus Healthcare
At Sensus Healthcare, we are committed to advancing patient care and empowering dermatology practices with innovative solutions. One of our most exciting developments in 2024 is the launch of the Fair Deal Agreement, a program designed to bring unprecedented value, efficiency, and growth opportunities to dermatology practices offering Superficial Radiation Therapy (SRT). What is the […]
Sensus Healthcare Buys Back Shares
BOCA RATON, Fla. – Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological skin conditions, announces that the company has resumed purchasing shares of its common stock in open-market transactions under a $3.0 million share repurchase program approved by its Board of […]
Sensus Healthcare Reports Fourth Quarter and Full Year 2024 Financial Results
Shipped a record 39 SRT systems during the quarter; revenues of $13.1 million Achieved fifth consecutive quarter of profitability; diluted EPS of $0.09 Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla. – Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for […]
